APO Research
Talk to an analyst

APO RESEARCH · REPORT

Premenstrual Syndrome Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Premenstrual Syndrome Medicine Industry Growth and Trends Forecast to 2032

26 December 202571 pages

Choose your research edition.

Industry ResearchPremenstrual Syndrome Medicine Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Premenstrual Syndrome Medicine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Premenstrual Syndrome Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Premenstrual Syndrome Medicine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Premenstrual Syndrome Medicine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Premenstrual Syndrome Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Premenstrual Syndrome Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Premenstrual Syndrome Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Premenstrual Syndrome Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Premenstrual Syndrome Medicine include Asarina Pharma AB and Pherin Pharmaceuticals Inc among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Premenstrual Syndrome Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Premenstrual Syndrome Medicine market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Premenstrual Syndrome Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Premenstrual Syndrome Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Premenstrual Syndrome Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Premenstrual Syndrome Medicine Market by Company

Asarina Pharma AB

Pherin Pharmaceuticals Inc

Premenstrual Syndrome Medicine Segment by Type

PH-80PMD

Progesterone

Estrogen

Others

Premenstrual Syndrome Medicine Segment by Application

Home Care

Hospital

Clinic

Premenstrual Syndrome Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premenstrual Syndrome Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Premenstrual Syndrome Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premenstrual Syndrome Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Premenstrual Syndrome Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Premenstrual Syndrome Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PH-80PMD Table 2. Major Company of Progesterone Table 3. Major Company of Estrogen Table 4. Major Company of Others Table 5. Global Premenstrual Syndrome Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 7. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Type (2021-2026) Table 10. Global Premenstrual Syndrome Medicine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Premenstrual Syndrome Medicine Sales by Type (2027-2032) & (W Units) Table 12. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Premenstrual Syndrome Medicine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Type (2027-2032) Table 15. Global Premenstrual Syndrome Medicine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 17. North America Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 19. Europe Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 23. Latin America Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Premenstrual Syndrome Medicine Sales by Type (2021-2026) & (US$ Million) Table 26. Premenstrual Syndrome Medicine Industry Trends Table 27. Premenstrual Syndrome Medicine Industry Drivers Table 28. Premenstrual Syndrome Medicine Industry Opportunities and Challenges Table 29. Premenstrual Syndrome Medicine Industry Restraints Table 30. Global Premenstrual Syndrome Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Premenstrual Syndrome Medicine Revenue Market Share by Company (2021-2026) Table 32. Global Premenstrual Syndrome Medicine Sales by Company (2021-2026) & (W Units) Table 33. Global Premenstrual Syndrome Medicine Sales Share by Company (2021-2026) Table 34. Global Premenstrual Syndrome Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Premenstrual Syndrome Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Premenstrual Syndrome Medicine Major Company Production Sites and Headquarters Table 37. Global Premenstrual Syndrome Medicine Company, Product Type & Application Table 38. Global Premenstrual Syndrome Medicine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Premenstrual Syndrome Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Premenstrual Syndrome Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Premenstrual Syndrome Medicine Sales by Region (2021-2026) & (W Units) Table 43. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Premenstrual Syndrome Medicine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Region (2021-2026) Table 46. Global Premenstrual Syndrome Medicine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Premenstrual Syndrome Medicine Sales by Region (2027-2032) & (W Units) Table 48. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Premenstrual Syndrome Medicine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Region (2027-2032) Table 51. Global Premenstrual Syndrome Medicine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Premenstrual Syndrome Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 54. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Application (2021-2026) Table 57. Global Premenstrual Syndrome Medicine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Premenstrual Syndrome Medicine Sales by Application (2027-2032) & (W Units) Table 59. Global Premenstrual Syndrome Medicine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Premenstrual Syndrome Medicine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Premenstrual Syndrome Medicine Sales Market Share in Value by Application (2027-2032) Table 62. Global Premenstrual Syndrome Medicine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 64. North America Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 66. Europe Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 70. Latin America Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Premenstrual Syndrome Medicine Sales by Application (2021-2026) & (US$ Million) Table 73. Asarina Pharma AB Company Information Table 74. Asarina Pharma AB Business Overview Table 75. Asarina Pharma AB Premenstrual Syndrome Medicine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Asarina Pharma AB Premenstrual Syndrome Medicine Product Portfolio Table 77. Asarina Pharma AB Recent Development Table 78. Pherin Pharmaceuticals Inc Company Information Table 79. Pherin Pharmaceuticals Inc Business Overview Table 80. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product Portfolio Table 82. Pherin Pharmaceuticals Inc Recent Development Table 83. North America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 84. North America Premenstrual Syndrome Medicine Sales by Country (2021-2026) & (W Units) Table 85. North America Premenstrual Syndrome Medicine Sales Market Share by Country (2021-2026) Table 86. North America Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032) & (W Units) Table 87. North America Premenstrual Syndrome Medicine Sales Market Share Forecast by Country (2027-2032) Table 88. North America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Premenstrual Syndrome Medicine Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Premenstrual Syndrome Medicine Market Share by Country (2021-2026) Table 91. North America Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Premenstrual Syndrome Medicine Market Share Forecast by Country (2027-2032) Table 93. Europe Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 94. Europe Premenstrual Syndrome Medicine Sales by Country (2021-2026) & (W Units) Table 95. Europe Premenstrual Syndrome Medicine Sales Market Share by Country (2021-2026) Table 96. Europe Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032) & (W Units) Table 97. Europe Premenstrual Syndrome Medicine Sales Market Share Forecast by Country (2027-2032) Table 98. Europe Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Premenstrual Syndrome Medicine Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Premenstrual Syndrome Medicine Market Share by Country (2021-2026) Table 101. Europe Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Premenstrual Syndrome Medicine Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Premenstrual Syndrome Medicine Sales by Country (2021-2026) & (W Units) Table 105. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share by Country (2021-2026) Table 106. Asia-Pacific Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032) & (W Units) Table 107. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Premenstrual Syndrome Medicine Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Premenstrual Syndrome Medicine Market Share by Country (2021-2026) Table 111. Asia-Pacific Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Premenstrual Syndrome Medicine Market Share Forecast by Country (2027-2032) Table 113. Latin America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. Latin America Premenstrual Syndrome Medicine Sales by Country (2021-2026) & (W Units) Table 115. Latin America Premenstrual Syndrome Medicine Sales Market Share by Country (2021-2026) Table 116. Latin America Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032) & (W Units) Table 117. Latin America Premenstrual Syndrome Medicine Sales Market Share Forecast by Country (2027-2032) Table 118. Latin America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Premenstrual Syndrome Medicine Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Premenstrual Syndrome Medicine Market Share by Country (2021-2026) Table 121. Latin America Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Premenstrual Syndrome Medicine Market Share Forecast by Country (2027-2032) Table 123. Middle East and Africa Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Middle East and Africa Premenstrual Syndrome Medicine Sales by Country (2021-2026) & (W Units) Table 125. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share by Country (2021-2026) Table 126. Middle East and Africa Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032) & (W Units) Table 127. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Premenstrual Syndrome Medicine Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East and Africa Premenstrual Syndrome Medicine Market Share by Country (2021-2026) Table 131. Middle East and Africa Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Premenstrual Syndrome Medicine Market Share Forecast by Country (2027-2032) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Premenstrual Syndrome Medicine Distributors List Table 136. Premenstrual Syndrome Medicine Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Premenstrual Syndrome Medicine Image Figure 2. Global Premenstrual Syndrome Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Premenstrual Syndrome Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Premenstrual Syndrome Medicine Sales (2021-2032) & (W Units) Figure 5. PH-80PMD Image Figure 6. Global PH-80PMD Sales YoY Growth (2021-2032) & (W Units) Figure 7. Progesterone Image Figure 8. Global Progesterone Sales YoY Growth (2021-2032) & (W Units) Figure 9. Estrogen Image Figure 10. Global Estrogen Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Premenstrual Syndrome Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Premenstrual Syndrome Medicine Market Share by Type 2025 VS 2032 Figure 15. North America Premenstrual Syndrome Medicine Sales Market Share in Volume by Type in 2025 Figure 16. North America Premenstrual Syndrome Medicine Sales Market Share in Value by Type in 2025 Figure 17. Europe Premenstrual Syndrome Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Premenstrual Syndrome Medicine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Premenstrual Syndrome Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Premenstrual Syndrome Medicine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Premenstrual Syndrome Medicine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Home Care Image Figure 28. Global Home Care Sales YoY Growth (2021-2032) & (W Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Premenstrual Syndrome Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Premenstrual Syndrome Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Premenstrual Syndrome Medicine Sales Market Share in Volume by Application in 2025 Figure 36. North America Premenstrual Syndrome Medicine Sales Market Share in Value by Application in 2025 Figure 37. Europe Premenstrual Syndrome Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Premenstrual Syndrome Medicine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Premenstrual Syndrome Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Premenstrual Syndrome Medicine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Premenstrual Syndrome Medicine Sales Market Share in Value by Application in 2025 Figure 45. North America Premenstrual Syndrome Medicine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Premenstrual Syndrome Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Premenstrual Syndrome Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Premenstrual Syndrome Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Premenstrual Syndrome Medicine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Premenstrual Syndrome Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Premenstrual Syndrome Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Premenstrual Syndrome Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Premenstrual Syndrome Medicine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Premenstrual Syndrome Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Premenstrual Syndrome Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Premenstrual Syndrome Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Premenstrual Syndrome Medicine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Premenstrual Syndrome Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Premenstrual Syndrome Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Premenstrual Syndrome Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Premenstrual Syndrome Medicine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Premenstrual Syndrome Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Premenstrual Syndrome Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Premenstrual Syndrome Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Premenstrual Syndrome Medicine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Premenstrual Syndrome Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • PH-80PMD
  • Progesterone
  • Estrogen
  • Others
Applications
  • Home Care
  • Hospital
  • Clinic
Companies covered
  • Asarina Pharma AB
  • Pherin Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Premenstrual Syndrome Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Premenstrual Syndrome Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Premenstrual Syndrome Medicine Market by Type
  6. 1.3.1 PH-80PMD
  7. 1.3.2 Progesterone
  8. 1.3.3 Estrogen
  9. 1.3.4 Others
  10. 1.4 Global Premenstrual Syndrome Medicine Market Size by Type
  11. 1.4.1 Global Premenstrual Syndrome Medicine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Premenstrual Syndrome Medicine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Premenstrual Syndrome Medicine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Premenstrual Syndrome Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Premenstrual Syndrome Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Premenstrual Syndrome Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Premenstrual Syndrome Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Premenstrual Syndrome Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Premenstrual Syndrome Medicine Industry Trends
  2. 2.2 Premenstrual Syndrome Medicine Industry Drivers
  3. 2.3 Premenstrual Syndrome Medicine Industry Opportunities and Challenges
  4. 2.4 Premenstrual Syndrome Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Premenstrual Syndrome Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Premenstrual Syndrome Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Premenstrual Syndrome Medicine Price (2021-2026)
  4. 3.4 Global Premenstrual Syndrome Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Premenstrual Syndrome Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Premenstrual Syndrome Medicine Company, Product Type & Application
  7. 3.7 Global Premenstrual Syndrome Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Premenstrual Syndrome Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Premenstrual Syndrome Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Premenstrual Syndrome Medicine Tier 1, Tier 2, and Tier 3
4 Premenstrual Syndrome Medicine Regional Status and Outlook
  1. 4.1 Global Premenstrual Syndrome Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Premenstrual Syndrome Medicine Historic Market Size by Region
  3. 4.2.1 Global Premenstrual Syndrome Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Premenstrual Syndrome Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Premenstrual Syndrome Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Premenstrual Syndrome Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Premenstrual Syndrome Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Premenstrual Syndrome Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Premenstrual Syndrome Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Premenstrual Syndrome Medicine by Application
  1. 5.1 Premenstrual Syndrome Medicine Market by Application
  2. 5.1.1 Home Care
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Premenstrual Syndrome Medicine Market Size by Application
  6. 5.2.1 Global Premenstrual Syndrome Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Premenstrual Syndrome Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Premenstrual Syndrome Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Premenstrual Syndrome Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Premenstrual Syndrome Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Premenstrual Syndrome Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Premenstrual Syndrome Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Premenstrual Syndrome Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Asarina Pharma AB
  2. 6.1.1 Asarina Pharma AB Company Information
  3. 6.1.2 Asarina Pharma AB Business Overview
  4. 6.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Product Portfolio
  6. 6.1.5 Asarina Pharma AB Recent Developments
  7. 6.2 Pherin Pharmaceuticals Inc
  8. 6.2.1 Pherin Pharmaceuticals Inc Company Information
  9. 6.2.2 Pherin Pharmaceuticals Inc Business Overview
  10. 6.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product Portfolio
  12. 6.2.5 Pherin Pharmaceuticals Inc Recent Developments
7 North America by Country
  1. 7.1 North America Premenstrual Syndrome Medicine Sales by Country
  2. 7.1.1 North America Premenstrual Syndrome Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Premenstrual Syndrome Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Premenstrual Syndrome Medicine Market Size by Country
  6. 7.2.1 North America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Premenstrual Syndrome Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Premenstrual Syndrome Medicine Sales by Country
  2. 8.1.1 Europe Premenstrual Syndrome Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Premenstrual Syndrome Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Premenstrual Syndrome Medicine Market Size by Country
  6. 8.2.1 Europe Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Premenstrual Syndrome Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Premenstrual Syndrome Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Premenstrual Syndrome Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Premenstrual Syndrome Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Premenstrual Syndrome Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Premenstrual Syndrome Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Premenstrual Syndrome Medicine Sales by Country
  2. 10.1.1 South America Premenstrual Syndrome Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Premenstrual Syndrome Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Premenstrual Syndrome Medicine Market Size by Country
  6. 10.2.1 South America Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Premenstrual Syndrome Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Premenstrual Syndrome Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Premenstrual Syndrome Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Premenstrual Syndrome Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Premenstrual Syndrome Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Premenstrual Syndrome Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Premenstrual Syndrome Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Premenstrual Syndrome Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Premenstrual Syndrome Medicine Value Chain Analysis
  2. 12.1.1 Premenstrual Syndrome Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Premenstrual Syndrome Medicine Production Mode & Process
  7. 12.2 Premenstrual Syndrome Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Premenstrual Syndrome Medicine Distributors
  10. 12.2.3 Premenstrual Syndrome Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst